Role of oxidative stress in cardiac dysfunction of PPARα−/− mice
about
Fatty old hearts: role of cardiac lipotoxicity in age-related cardiomyopathyModulation of Hypercholesterolemia-Induced Oxidative/Nitrative Stress in the HeartPPARs: Protectors or Opponents of Myocardial Function?Regulation of ENaC-Mediated Sodium Reabsorption by Peroxisome Proliferator-Activated ReceptorsAltered cross-bridge properties in skeletal muscle dystrophiesCardiomyocyte aldose reductase causes heart failure and impairs recovery from ischemia.Trolox and ascorbic acid reduce direct and indirect oxidative stress in the IPEC-J2 cells, an in vitro model for the porcine gastrointestinal tractCardiac dysfunction in adipose triglyceride lipase deficiency: treatment with a PPARα agonist.The story so far: post-translational regulation of peroxisome proliferator-activated receptors by ubiquitination and SUMOylation.Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions.Anticancer Properties of PPARalpha-Effects on Cellular Metabolism and Inflammation.In vivo mouse cardiac hyperpolarized magnetic resonance spectroscopy.Cardiac Myosin-binding protein C modulates the tuning of the molecular motor in the heartCardiac Myocyte KLF5 Regulates Ppara Expression and Cardiac FunctionPeroxisome-proliferator-activated receptors regulate redox signaling in the cardiovascular systemCardiac oxidative stress in a mouse model of neutral lipid storage disease.Cardiac peroxisome proliferator-activated receptor-γ expression is modulated by oxidative stress in acutely infrasound-exposed cardiomyocytesBezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and FibrosisMinireview: Won't get fooled again: the nonmetabolic roles of peroxisome proliferator-activated receptors (PPARs) in the heart.PPARs, Cardiovascular Metabolism, and Function: Near- or Far-from-Equilibrium Pathways.Role of Pleiotropic Properties of Peroxisome Proliferator-Activated Receptors in the Heart: Focus on the Nonmetabolic Effects in Cardiac Protection.The Positive Regulation of eNOS Signaling by PPAR Agonists in Cardiovascular Diseases.A dose-dependent perturbation in cardiac energy metabolism is linked to radiation-induced ischemic heart disease in Mayak nuclear workers.PGC-1 alpha regulates expression of myocardial mitochondrial antioxidants and myocardial oxidative stress after chronic systolic overload.Alterations in carbohydrate metabolism and its regulation in PPARalpha null mouse hearts.Physiological role of free radicals in skeletal muscles.Proteomics landscape of radiation-induced cardiovascular disease: somewhere over the paradigm.MicroRNA-21 regulates peroxisome proliferator-activated receptor alpha, a molecular mechanism of cardiac pathology in Cardiorenal Syndrome Type 4.Apoptosis and fibrosis are early features of heart failure in an animal model of metabolic cardiomyopathy.Fenofibrate Therapy Restores Antioxidant Protection and Improves Myocardial Insulin Resistance in a Rat Model of Metabolic Syndrome and Myocardial Ischemia: The Role of Angiotensin II.Cardiac hypertrophy is enhanced in PPAR -/- mice in response to chronic pressure overloadTempol prevents cardiac oxidative damage and left ventricular dysfunction in the PPAR-α KO mousePPARα: essential component to prevent myocardial oxidative stress?
P2860
Q26739009-9EAD43BB-DF6B-409D-9661-5AF5A54CF6B7Q26770809-346ACCF1-C00E-4794-A8E0-AE7E9AB67DA5Q26771753-C75D83A9-E14C-414F-A43C-026DE4FE73C6Q33960919-62712203-14DD-444A-B1AA-77EC35849E8EQ34335939-B9FA6A83-A59F-4127-A8E7-ADB28491BFABQ34431401-F0692967-873F-4834-BABA-354C925B6D4AQ35572685-4B891F3C-8EED-4D05-9FA9-70609B1EA957Q35708138-47A77076-3E18-4575-8274-7A83BA79E713Q35964903-7BDBF4E3-EA80-4B8E-A5CC-26C4C9849B4BQ36261125-13F02DFA-B987-4398-9A9F-A5C50E28D036Q36675898-12B0D69A-61FF-43D8-972C-780DEB6C3D5AQ36690325-59B55E80-8C9D-408A-A7D3-7941E620D691Q36737220-56C2560B-C56D-4BB3-99B4-1BEAA5EE0CC4Q36950315-1ACEE39E-CA64-412B-84E4-01E90960BE62Q36952106-0022C319-68E6-4A28-8045-F3E1924F71C6Q37226723-E837F574-B712-4544-A32F-D0DA7EC8CB34Q37325731-0860CC07-3699-4E93-B2CC-1461ABFC8B0AQ37588749-F3752B5D-DE47-4939-8768-47CC8BBB9573Q37656896-0BBC41A2-8293-4FD5-95FF-C5F1DD740CD3Q37779741-1F5F13E0-F3DF-4D8D-AE24-37A0C66E9010Q38640842-BDCA7222-84B5-4809-ACD3-AB805B31F5E5Q39185669-FF3DC381-8428-4396-B290-380AD824496BQ39621874-40A7C995-A6E0-4071-8F58-4760C3DBD715Q42406946-F59CE092-2E76-4772-B85A-41AFAC87F13DQ46788971-13F0612B-5BB2-4959-974E-F6BBB961DF44Q46966215-E19C4B83-A8EC-40C5-B78F-8EE6D420B354Q47868740-33CA8D87-A8F3-4511-B878-020B8733DD89Q49620885-7E5386E4-10E8-41EB-859A-EBFE90D0CF9FQ50451828-72A50E9A-0A12-4C77-852A-9DC6B8E2A496Q51226497-2E6757C7-F621-4054-930B-2CB205EC275CQ57244167-27EDEC27-96A0-46AD-8276-AA0C820BB0E1Q57907026-12C193B7-8099-4DC3-919B-31493F4B93A3Q59200913-E6633191-0DF2-4EE9-81F7-06741B6B6F05
P2860
Role of oxidative stress in cardiac dysfunction of PPARα−/− mice
description
im März 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 16 March 2007
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2007
@uk
name
Role of oxidative stress in cardiac dysfunction of PPARα−/− mice
@en
Role of oxidative stress in cardiac dysfunction of PPARα−/− mice
@nl
type
label
Role of oxidative stress in cardiac dysfunction of PPARα−/− mice
@en
Role of oxidative stress in cardiac dysfunction of PPARα−/− mice
@nl
prefLabel
Role of oxidative stress in cardiac dysfunction of PPARα−/− mice
@en
Role of oxidative stress in cardiac dysfunction of PPARα−/− mice
@nl
P2093
P2860
P50
P1476
Role of oxidative stress in cardiac dysfunction of PPARalpha-/- mice
@en
P2093
Aziz Guellich
Jean-Louis Hébert
Jeanine Quillard
Marc Conti
Thibaud Damy
Thierry Pineau
Yves Lecarpentier
P2860
P304
P356
10.1152/AJPHEART.00037.2007
P577
2007-03-16T00:00:00Z